Ferumoxytol potentiates ferroptotic radiosensitization through NCOA4-associated iron mobilization in brain-metastatic lung cancer cells
4 affiliations
- 1Department of Radiation Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People’s Hospital of Lianyungang
- 2Department of Radiation Oncology, The First People’s Hospital of Lianyungang/Lianyungang Clinical College of Nanjing Medical University
- 3Lianyungang Medical-Education Innovation and Research Center, Nanjing Medical University
- 4Department of Radiation Oncology, Southeast University Affiliated Xuzhou Central Hospital
Abstract
Background: Brain metastasis remains a major cause of mortality in patients with advanced non-small cell lung cancer, whereas effective radiosensitization strategies are constrained by heterogeneous tumor responses and the tolerance of normal brain tissue. Ferumoxytol, a clinically used iron oxide nanoparticle formulation, has emerging translational potential as an iron-modulating agent. However, whether Ferumoxytol enhances radiosensitivity in brain-metastatic lung cancer cells and the mechanisms underlying this effect remain unclear.
Methods: PC-9 lung adenocarcinoma cells and NCI-H1915 brain-metastatic lung adenocarcinoma cells were used to evaluate ferumoxytol under basal and irradiated conditions. Ferroptosis-associated phenotypes, oxidative stress, clonogenic survival, and cell-cycle distribution were assessed. TMT-based proteomics and public single-cell and spatial transcriptomic analyses were used for candidate prioritization and disease-context support. NCOA4 was evaluated by siRNA-mediated loss of function, single-dose clonogenic assays, time-resolved NCOA4/FTH1 immunoblotting, bafilomycin A1-based autophagic-flux analysis, and endogenous NCOA4-FTH1 co-immunoprecipitation.
Results: Ferumoxytol induced mitochondrial, biochemical, and molecular changes consistent with ferroptosis and enhanced irradiation-associated ROS accumulation, lipid peroxidation, and loss of clonogenic survival. Proteomic analysis prioritized NCOA4, while public transcriptomic analyses provided associative disease-context support. In H1915 cells, NCOA4 silencing attenuated combined-treatment Fe ²⁺ accumulation, oxidative stress, and γ-H2AX induction. The incremental reduction in colony formation produced by adding ferumoxytol to irradiation was also reduced after NCOA4 knockdown in H1915 cells and was no longer significant in PC-9 cells. Time-resolved immunoblotting showed marked FTH1 accumulation rather than net FTH1 depletion, with a late reduction in NCOA4. Bafilomycin A1 caused further LC3B-II and SQSTM1/p62 accumulation under IR + F, consistent with ongoing autophagic turnover, whereas co-immunoprecipitation showed greater normalized recovery of FTH1 in NCOA4 immunoprecipitates after IR + F.
Conclusion: Ferumoxytol enhances ferroptosis-associated oxidative injury and radiosensitivity in the tested lung cancer cell models. The combined loss-of-function, autophagic-flux, and protein-interaction data support the involvement of NCOA4-associated ferritin handling and iron mobilization. However, the observed FTH1 accumulation and the absence of iron-chelator rescue, cargo-specific lysosomal tracking, and in vivo validation preclude a definitive claim of canonical ferritinophagy or clinical efficacy.
Related
- Long-Term Microplastic Accumulation Is Associated with Element-Specific Heavy Metal Mobilization in Agricultural Soils: Field Evidence from the Anning Valley, China
- Ferumoxytol-Enhanced Cardiac Magnetic Resonance for Delineation of Hyperacute Intramyocardial Hemorrhage with Ex Vivo Validation
- Jing Si Herbal Tea Aqueous Extract Modulates G-CSF-Induced Hematopoietic Stem and Progenitor Cells Mobilization and Mitigates Associated Pain in a Murine Model.
- Early mobilization after reverse total shoulder arthroplasty is not associated with increased risk of acromial and scapular stress fractures: a retrospective cohort study.
- Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR.
BibTeX
@article{shen2026ferumoxytol,
title = {{Ferumoxytol potentiates ferroptotic radiosensitization through NCOA4-associated iron mobilization in brain-metastatic lung cancer cells}},
author = {Ziqiang Shen and Jiangrui Zhu and Yongliu Yang and Jing Yang and Lisha Rao and Chong Zhou and Youyou Xia},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1883092},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1883092/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Ferumoxytol potentiates ferroptotic radiosensitization through NCOA4-associated iron mobilization in brain-metastatic lung cancer cells
AU - Ziqiang Shen
AU - Jiangrui Zhu
AU - Yongliu Yang
AU - Jing Yang
AU - Lisha Rao
AU - Chong Zhou
AU - Youyou Xia
PY - 2026
DA - 2026/10/14
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1883092
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1883092/full
AB - Background: Brain metastasis remains a major cause of mortality in patients with advanced non-small cell lung cancer, whereas effective radiosensitization strategies are constrained by heterogeneous tumor responses and the tolerance of normal brain tissue. Ferumoxytol, a clinically used iron oxide nanoparticle formulation, has emerging translational potential as an iron-modulating agent. However, whether Ferumoxytol enhances radiosensitivity in brain-metastatic lung cancer cells and the mechanisms underlying this effect remain unclear. Methods: PC-9 lung adenocarcinoma cells and NCI-H1915 brain-metastatic lung adenocarcinoma cells were used to evaluate ferumoxytol under basal and irradiated conditions. Ferroptosis-associated phenotypes, oxidative stress, clonogenic survival, and cell-cycle distribution were assessed. TMT-based proteomics and public single-cell and spatial transcriptomic analyses were used for candidate prioritization and disease-context support. NCOA4 was evaluated by siRNA-mediated loss of function, single-dose clonogenic assays, time-resolved NCOA4/FTH1 immunoblotting, bafilomycin A1-based autophagic-flux analysis, and endogenous NCOA4-FTH1 co-immunoprecipitation. Results: Ferumoxytol induced mitochondrial, biochemical, and molecular changes consistent with ferroptosis and enhanced irradiation-associated ROS accumulation, lipid peroxidation, and loss of clonogenic survival. Proteomic analysis prioritized NCOA4, while public transcriptomic analyses provided associative disease-context support. In H1915 cells, NCOA4 silencing attenuated combined-treatment Fe ²⁺ accumulation, oxidative stress, and γ-H2AX induction. The incremental reduction in colony formation produced by adding ferumoxytol to irradiation was also reduced after NCOA4 knockdown in H1915 cells and was no longer significant in PC-9 cells. Time-resolved immunoblotting showed marked FTH1 accumulation rather than net FTH1 depletion, with a late reduction in NCOA4. Bafilomycin A1 caused further LC3B-II and SQSTM1/p62 accumulation under IR + F, consistent with ongoing autophagic turnover, whereas co-immunoprecipitation showed greater normalized recovery of FTH1 in NCOA4 immunoprecipitates after IR + F. Conclusion: Ferumoxytol enhances ferroptosis-associated oxidative injury and radiosensitivity in the tested lung cancer cell models. The combined loss-of-function, autophagic-flux, and protein-interaction data support the involvement of NCOA4-associated ferritin handling and iron mobilization. However, the observed FTH1 accumulation and the absence of iron-chelator rescue, cargo-specific lysosomal tracking, and in vivo validation preclude a definitive claim of canonical ferritinophagy or clinical efficacy.
SN - 1663-9812
ER -